General MedicationsORALStandard
TIOPRONIN
TIOPRONIN
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TIOPRONIN is listed in Drugs@FDA under application 217219 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TIOPRONIN Form and strength TABLET, DELAYED RELEASE;ORAL - 300MG Sponsor PH HEALTH Submission history Latest submission status date: 2023-02-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview TIOPRONIN is listed in Drugs@FDA under application 217219 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TIOPRONIN Form and strength TABLET, DELAYED RELEASE;ORAL - 300MG Sponsor PH HEALTH Submission history Latest submission status date: 2023-02-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.